AAX Biotech provides proprietary platforms that streamline antibody drug development. Seqitope® delivers high‑resolution, high‑throughput epitope mapping for up to 100 monoclonal antibodies, while Opti‑mAb® stabilizes scFv formats to boost expression yields and reduce aggregation, supporting therapeutic and diagnostic antibody programs.

Apotekamo is an online pharmacy marketplace that provides traditional pharmacies with a digital sales platform, enhancing their visibility and access to a broader customer base. This solution addresses the challenge of limited online presence for local pharmacies, enabling them to compete effectively in the growing e-commerce landscape.

E INC enhances the automotive purchasing process by providing a digital platform that streamlines wholesale and retail transactions through advanced technology and data analytics. This approach addresses inefficiencies in the automotive ecosystem, enabling faster and more flexible business operations for dealers and consumers.

The startup has developed an esports platform that facilitates stake-to-play challenges through fully automated daily tournaments across various game modes. This platform enables gamers of all skill levels to participate in competitive matches for prize money and digital rewards, addressing the need for accessible and engaging gaming experiences.

HARM provides an AI-powered platform for individuals experiencing harm to quickly access immediate, trusted support. The system intelligently identifies the nature of the reported harm and routes users directly to appropriate, city-approved advocacy, legal, or housing resources. This streamlined process eliminates confusion while generating de-identified data insights to help municipal leaders optimize community support services.

<name>Hi</name> <description>Hi provides a licensed crypto‑fiat neobank platform that enables users to trade over 100 cryptocurrencies alongside traditional fiat currencies. The app combines trading, yield‑earning savings accounts, and payment functionality in a single mobile interface. Users can set flexible crypto savings goals and withdraw funds at any

Klarna offers a payments platform that embeds flexible financing options—including interest‑free Pay in 4 installments, pay‑later, and longer‑term credit—into online and in‑store checkout experiences. The service manages credit underwriting, payment collection, dispute handling, and buyer‑protection workflows, delivering merchants a consolidated settlement and conversion analytics. Shoppers can track orders, manage balances, and receive cashback through the Klarna mobile app.

LEA utilizes AI and optical character recognition (OCR) technology to extract and classify financial data from various documents, enabling registered investment advisors (RIAs) to efficiently access their clients' complete financial profiles. This streamlined process reduces the cost of delivering targeted financial advice, allowing advisors to focus on high-value interactions and growth opportunities.

Lunar is a digital banking platform that provides a mobile app for personal finance management, enabling users to track spending, budget effectively, and earn interest on deposits up to 1.50%. The service eliminates traditional banking fees and offers features like investment options and travel rewards, addressing the need for a cost-effective and user-friendly banking solution.

Lo provides a platform for managing and automating commercial real estate leasing workflows. It centralizes lease documentation, tracks key dates, and streamlines communication between landlords and tenants. This system helps commercial property managers reduce administrative overhead and ensure compliance across their portfolio.

Oblique Therapeutics utilizes its proprietary AbiProt® technology to develop antibody-based medications targeting chronic pain and metastatic cancer, focusing on previously undruggable clinical targets. This approach aims to provide effective treatment options for patients with limited alternatives in these challenging medical conditions.

Provides a business intelligence platform powered by GPT-4o that enables users to query data in natural language and receive real-time insights. It simplifies data analysis for business owners and managers by eliminating the need for complex querying languages, making data-driven decision-making more accessible.

PeptiSystems manufactures fully automated synthesizers utilizing continuous flow technology for the production of peptide and oligonucleotide therapeutics, significantly reducing synthesis time from weeks to just 1-3 hours. Their systems provide real-time monitoring and consistent scalability, enabling efficient process development and large-scale manufacturing while improving yield and purity by up to 15%.

PharmNovo AB is a clinical-stage pharmaceutical company developing PN6047, a drug candidate that selectively targets the delta opioid receptor to provide effective relief from neuropathic pain. Unlike conventional opioids, PN6047 has demonstrated safety and tolerability in Phase I trials, with no serious adverse events or common opioid-related side effects.

RA UNLIMITED harnesses solar photovoltaic technology to generate clean and affordable electricity for homes, businesses, and communities in the Philippines. The company addresses the reliance on fossil fuels by providing sustainable energy solutions that create jobs and enhance the quality of life for Filipinos.

Re is an on‑chain reinsurance protocol that tokenizes real reinsurance treaties, issuing fully collateralized tokens backed by verified insurance premiums. The platform provides institutional investors and insurers with regulated, transparent access to the $800B+ reinsurance market, delivering 8‑16% annual yields that are largely uncorrelated with traditional assets while maintaining defined risk limits and underwriting discipline.

The startup has developed a respiratory monitoring technology that provides continuous, real-time measurements of diaphragm function and respiratory muscle activity in critically ill patients. This precise data enables healthcare providers to enhance patient care quality while reducing associated treatment costs in intensive care settings.

SAGA Diagnostics specializes in molecular residual disease (MRD) detection using a proprietary platform that combines next-generation sequencing and digital PCR to create patient-specific genetic fingerprints from tumor samples. This technology enables ultra-sensitive monitoring of residual cancer post-treatment, facilitating timely and informed therapeutic decisions through simple blood draws.

Sniph offers a subscription service that delivers personalized perfume samples each month, allowing users to explore over 500 curated scents from renowned fragrance houses. This model addresses the challenge of finding new fragrances that match individual preferences without the need for costly full-size purchases.

SpaceX designs and manufactures reusable rockets to significantly lower the costs of space travel. By enabling multiple launches with the same hardware, the company addresses the high expenses associated with traditional single-use launch systems.

The startup develops a biopharmaceutical platform that utilizes proprietary peptides to provide anti-inflammatory and antibacterial treatments for wound care and topical applications. This technology addresses the need for effective therapies in a market increasingly challenged by multi-drug resistant infections.

Yaytrade is a global marketplace that connects consumers, influencers, and businesses to buy and sell new and pre-owned lifestyle items at discounts of 50-80%. The platform enables smarter shopping by allowing users to try items before purchasing, thereby reducing waste and promoting sustainable consumption.